Abstract: Disclosed is a resolver, which includes a stator having at least one excitation coil and at least one output coil, and a rotor disposed at a center space in the stator with a predetermined gap from the stator, the rotor rotating based on a rotary shaft to change a gap permeance with respect to the stator, wherein the stator includes a back yoke having a ring-shaped body, and a plurality of teeth formed at an inner circumference of the back yoke so that the excitation coil and the output coil are wound thereon, wherein the rotor includes a ring-shaped body having a center hole into which the rotary shaft is inserted, and a plurality of salient poles formed at an outer circumference of the ring-shaped body.

Abstract: Disclosed is a resolver, which includes a stator made of a magnetic material and having a plurality of teeth and a plurality of slots alternately formed at an inner side thereof; insulation covers respectively having a tooth insulating unit formed at an inner side thereof corresponding to the teeth and mounted to the stator at both upper and lower surfaces of the stator; and coils wound on the teeth with the tooth insulating unit being interposed therebetween, wherein a coil occupying ratio per slot, which is defined by the following equation and represents a ratio of area occupied by the coils in a slot to which the insulation covers are fixed, is 35% or below: Coil occupying ratio per slot=(area occupied by coils in a single slot)/(area of a single slot).

Abstract: Disclosed is a resolver robust against external noise and having a reduced error in the detection of a rotation angle, which includes a stator made of a magnetic material and having a plurality of teeth and a plurality of slots alternately formed at an inner side thereof, insulation covers respectively having a tooth insulating unit formed at an inner side thereof corresponding to the teeth and mounted to the stator at both upper and lower surfaces of the stator, and coils wound on the teeth with the tooth insulating unit being interposed therebetween, wherein regarding winding widths of coils located at an outermost circumference among the wound coils, a ratio of a shortest winding width to a longest winding width is 0.69 or above and 1 or below.

Abstract: The present invention relates to a recombinant adenovirus with increased in-vivo safety, tissue specificity, and anticancer activities, and a use thereof. Specifically, the recombinant adenovirus comprising: a promoter of the liver tissue-specific phosphoenolpyruvate carboxykinase (PEPCK) gene; a trans-splicing ribozyme which is operably linked to the promoter and acts on a cancer-specific gene; a therapeutic gene or a reporter gene which is linked to the 3? exon of the ribozyme; and a serotype 35 fiber knob and a serotype 5 shaft, in which the orf4 gene is deleted from adenovirus E1, E3 and E4 orf1, shows remarkable in-vivo safety, high specificity for a target tissue, and remarkable anticancer effects, and thus can be useful for an anticancer drug or a cancer diagnostic agent as a gene delivery vector.

Abstract: Embodiments of the present invention provide a bluish green phosphor represented by Formula 1 below. In particular, the bluish green phosphor and a light emitting device package including the same may have superior luminescence characteristics and improved temperature stability by selecting composition ratios of each ingredients included in a composition formula and ions and thereby minimizing lattice defects in a crystal structure: AaBbOcNdGe:REh??[Formula 1] wherein A is at least one selected from the group consisting of Be, Mg, Ca, Sr, Ba and Ra elements, B is at least one selected from the group consisting of Si, Ge and Sn elements, O means oxygen, N means nitrogen, G is any one of C, Cl, F and Br elements, C means Carbon, RE is at least one selected from the group consisting of Eu, Ce, Sm, Er, Yb, Dy, Gd, Tm, Lu, 0<a?15, 0<b?15, 0<c?15, 0<d?20, 0<e?10, and 0<h?10.

Abstract: The present invention relates to a recombination vector, a transformation cell into which the recombinant vector is introduced, a ribozyme expressed from the recombination vector, a prophylactic or therapeutic composition for liver cancer comprising the recombination vector and the ribozyme, and a therapeutic method for liver cancer using the composition, said recombination vector comprising: a tissue-specific promoter; and a ribozyme-target gene expression cassette comprising a trans-splicing ribozyme targeting a cancer-specific gene and a target gene connected to the 3? exon of the ribozyme, wherein a splicing donor/splicing acceptor sequence (SD/SA sequence) is connected to the 5? end of the ribozyme-target gene expression cassette, woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) is connected to the 3? end of the ribozyme-target gene expression cassette, and a nucleic acid sequence recognizing a micro RNA-122a (microRNA-122a, miR-122a) is further connected to the 3? end of the WPRE.

Abstract: Provided is a substrate treating apparatus. The substrate treating apparatus includes an equipment front end module, a loadlock chamber, a transfer chamber, and a plurality of process chambers. The loadlock chamber includes a cooling unit for cooling a substrate treated in the process chambers, and the cooling unit includes a cooling chamber having an inner space, the cooling chamber having a gas inflow hole in one surface thereof, wherein support pins on which the substrate is placed are disposed around a circumference of the gas injection hole, a cooling gas injection part supplying a cooling gas toward the gas inflow hole, and a gas exhaust part exhausting the cooling gas supplied into the cooling chamber and fumes generated from the substrate to the outside of the cooling chamber.

Abstract: Embodiments of the present invention provide a bluish green phosphor represented by Formula 1 below. In particular, the bluish green phosphor and a light emitting device package including the same may have improved luminescence characteristics and properties due to influence of cations and anions included in a composition formula: AaBbOcNdGeDfEg:REh??[Formula 1] wherein A is at least one selected from the group consisting of Be, Mg, Ca, Sr, Ba and Ra elements, B is at least one selected from the group consisting of Si, Ge and Sn elements, G is any one of C, Cl, F and Br elements, D is one element or a mixture type of two or more elements selected from Li, Na and K, E is at least one selected from the group consisting of P, As, Bi, Sc, Y and Lu, RE is at least one selected from the group consisting of Eu, Ce, Sm, Er, Yb, Dy, Gd, Tm, Lu, Pr, Nd, Pm and Ho, 0<a?15, 0<b?15, 0<c?15, 0<d?20, 0<e?10, 0<f?6, 0<g?6, and 0<h?10.

Abstract: Provided is a method of transmitting transport stream packets from a terminal connected to a network including generating a time stamp with reference to time information managed in synchronization with other terminals by a medium access control (MAC) layer in order to control medium use in the network; processing the transport stream packets by using the time stamp; and transmitting the processed transport stream packets.

Abstract: Embodiments of the present invention provide a bluish green phosphor represented by Formula 1 below. In particular, the bluish green phosphor and a light emitting device package including the same may have superior luminesence characteristics and improved temperature stability by selecting composition ratios of each ingredients included in a composition formula and ions and thereby minimizing lattice defects in a crystal structure: AaBbOcNdCe:REh??[Formula 1] wherein A is at least one selected from the group consisting of Be, Mg, Ca, Sr, Ba and Ra elements, B is at least one selected from the group consisting of Si, Ge and Sn elements, C is any one of C, Cl, F and Br elements, RE is at least one selected from the group consisting of Eu, Ce, Sm, Er, Yb, Dy, Gd, Tm, Lu, 0<a?15, 0<b?15, 0<c?15, 0<d?20, 0<e?10, and 0<h?10.

Abstract: The present invention relates to an aptazyme comprising an aptamer for hepatitis C virus (HCV) RNA-encoding component; a hammerhead ribozyme comprising an antisense sequence to microRNA at the site released by self-cleavage; and a communication module sequence that connects the aptamer and hammerhead ribozyme and triggers a self-cleavage activity of the hammerhead ribozyme upon binding of the aptamer with the HCV RNA-encoding component. The present aptazyme inhibits microRNA activity specifically in HCV proliferating cells and thus a composition of the present invention comprising the aptazyme can be effectively used for treatment of HCV-related diseases.

Abstract: Embodiments of the present invention provide a bluish green phosphor represented by Formula 1 below. In particular, the bluish green phosphor and a light emitting device package including the same may have improved luminescence characteristics and properties due to influence of cations and anions included in a composition formula: AaBbOcNdCeDfEg:REh??[Formula 1] wherein A is at least one selected from the group consisting of Be, Mg, Ca, Sr, Ba and Ra elements, B is at least one selected from the group consisting of Si, Ge and Sn elements, C is any one of C, Cl, F and Br elements, D is one element or a mixture type of two or more elements selected from Li, Na and K, E is at least one selected from the group consisting of P, As, Bi, Sc, Y and Lu, RE is at least one selected from the group consisting of Eu, Ce, Sm, Er, Yb, Dy, Gd, Tm, Lu, Pr, Nd, Pm and Ho, 0<a?15, 0<b?15, 0<c?15, 0<d?20, 0<e?10, 0<f?6, 0<g?6, and 0<h?10.

Abstract: Provided herein is a flame-retardant polyolefin resin containing a blend which comprises 1-80 wt % of piperazine metal salts or polymers thereof, 10-80.0 wt % of nitrogen-containing synergists or phosphorus/nitrogen retardants, and 1-50 wt % of inorganic compounds, wherein the sum of the components of the blend is 100 wt %.

Abstract: A multi-view device for use in conjunction with a display apparatus is provided. The device includes: a lens unit which operates to selectively transmit or block light; a communication unit which communicates with the display apparatus which is displaying a content image; and a controller which receives a beacon signal in synchronization with a display period of the content image from the display apparatus via the communication unit, controls an operation of the lens unit based on the received beacon signal, and changes a reception frequency of the beacon signal in accordance with a running time of the content image displayed on the display apparatus.

Abstract: The present invention relates to a recombinant adenovirus with increased in-vivo safety, tissue specificity, and anticancer activities, and a use thereof. Specifically, the recombinant adenovirus comprising: a promoter of the liver tissue-specific phosphoenolpyruvate carboxykinase (PEPCK) gene; a trans-splicing ribozyme which is operably linked to the promoter and acts on a cancer-specific gene; a therapeutic gene or a reporter gene which is linked to the 3? exon of the ribozyme; and a serotype 35 fiber knob and a serotype 5 shaft, in which the orf4 gene is deleted from adenovirus E1, E3 and E4 orf1, shows remarkable in-vivo safety, high specificity for a target tissue, and remarkable anticancer effects, and thus can be useful for an anticancer drug or a cancer diagnostic agent as a gene delivery vector.

Abstract: Provided is a method of transmitting transport stream packets from a terminal connected to a network including generating a time stamp with reference to time information managed in synchronization with other terminals by a medium access control (MAC) layer in order to control medium use in the network; processing the transport stream packets by using the time stamp; and transmitting the processed transport stream packets.

Abstract: Provided is a method of processing and transmitting transport stream packets and processing the transmitted transport stream packets. A time stamp is generated in a medium access control (MAC) layer based on time information managed by the MAC layer, and a data frame including the transport stream packets is retransmitted based on an algorithm different from that used for a general data frame when a transmission error occurs. Therefore, there is no need to transmit and receive additional synchronization packets in order to precisely transmit the transport stream packets between transmitting and receiving terminals, and it is possible to reduce performance deterioration caused by latency and jitter.

Abstract: Provided are RNA aptamer specifically binding to cancer metastasis-inducing domain of CEA (Carcinoembryonic antigen), a composition for prevention and/or inhibition and/or diagnosis of cancer metastasis containing the same as an active ingredient, and a method of prevention and/or inhibition and/or diagnosis of cancer metastasis using the same.

Abstract: Provided is a substrate treating apparatus. The substrate treating apparatus includes an equipment front end module, a loadlock chamber, a transfer chamber, and a plurality of process chambers. The loadlock chamber includes a cooling unit for cooling a substrate treated in the process chambers, and the cooling unit includes a cooling chamber having an inner space, the cooling chamber having a gas inflow hole in one surface thereof, wherein support pins on which the substrate is placed are disposed around a circumference of the gas injection hole, a cooling gas injection part supplying a cooling gas toward the gas inflow hole, and a gas exhaust part exhausting the cooling gas supplied into the cooling chamber and fumes generated from the substrate to the outside of the cooling chamber.

Abstract: To check security of an Access Point (AP) in a wireless communication system, an operating method of a terminal includes, before completing connection to the AP, receiving a frame that informs the terminal of existence of the AP; extracting security test information from the frame; and testing the security of the AP using the security test information.